EZH2 and hepatocellular carcinoma: To gain a comprehensive understanding of the transcriptional dynamics induced by the inhibition of EZH2-mediated H3K27me3, we performed RNA sequencing on an HCC cell line treated with tazemetostat, as well as with EZH2 knockdown (Supplementary Fig. 2A).